Conference Coverage: ESMO 2024 – Focus on Gastrointestinal (GI) Malignancies
GI cancer-specific discussions on therapeutic advances and their application in clinical decision-making
September 19, 2024
Faculty Chair
Tanios S. Bekaii-Saab, MD, FACP
Mayo Clinic, Phoenix, AZ, USA
FACULTY MEMBERS
Dirk Arnold, MD, PhD
University of Hamburg, Germany
Cathy Eng, MD, FACP, FASCO
Vanderbilt-Ingram Cancer Center, Nashville, TN, USA
Philip A. Philip, MD, PhD, FABC
Henry Ford Cancer Institute, Detroit, MI, USA
Julien Taieb, MD, PhD
Georges Pompidou European Hospital, Paris, France
Nataliya Uboha, MD, PhD
University of Wisconsin Carbone Cancer Center, Madison, WI, USA
Alan Venook, MD, FASCO
Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Metastatic Colorectal Cancer (mCRC) – Including Targeted Therapy
- Microsatellite Stable (MSS) and High Microsatellite Instability (MSI-H) CRC
- Rectal Cancer
- Gastric and Gastroesophageal Junction (GEJ) Cancers
- Pancreatic Cancer and Biliary Tract Cancer
- Hepatocellular Carcinoma (HCC)
